Longitudinal follow-up of depressive symptoms among normal versus cognitively impaired elderly

International Journal of Geriatric Psychiatry

Volumn 16, Issue 7, 2001, Pages 718-727

  Li, Yan Sheng ^a,b   Meyer, John S ^a,b   Thornby, John ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's dementia; Depressive symptoms; Incidence; Mild cognitive impairment; Prevalence; Risk factors; Treatment; Vascular dementia

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; FLUOXETINE; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DEMENTIA; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE RESISTANCE; DISEASE SEVERITY; ELDERLY CARE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HAMILTON SCALE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NERVE CELL DEGENERATION; NEUROLOGIC EXAMINATION; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; REMISSION; RISK ASSESSMENT; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME; VOLUNTEER;

AGED; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; COGNITION DISORDERS; DEMENTIA, VASCULAR; DEPRESSION; DISEASE PROGRESSION; HUMANS; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; TEXAS; TREATMENT OUTCOME;

EID: 0034864445     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.423     Document Type: Article

References (57)

1. Vascular depression hypothesis
2. The influence of depressive symptomatology on episodic memory functioning among clinically nondepressed older adults
3. The prevalence, associations and symptoms of depression amongst dementia sufferers
4. A one-year follow-up study of depression in dementia sufferers
5. The occurrence of depressive symptoms in the preclinical phase of AD: A population-based study
6. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment
7. Age-associated memory impairment: Proposed criteria and measures of clinical changes. Report of the National Institute of Mental Health Work Group
8. Dementia and depression: An evolving enigma
9. Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited
10. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community
11. Questionable dementia: Clinical course and predictors of outcome
12. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease
13. Depression in dementia of the Alzheimer type and in multi-infarct dementia
14. 'Mini-mental state': A practical method for grading the cognitive state of patients for the clinician
15. Association of age, sex, cognitive dysfunction, and disability with major depressive symptoms in an elderly sample
16. Major depression in a population of demented and nondemented older people: Prevalence and correlates
17. Mild cognitive impairment raises Alzheimer disease risk
18. Cerebrovascular disease affects noncognitive symptoms and motor function rather than cognition in mild AD
19. Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease?
20. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression
21. A rating scale for depression
22. A follow-up study of age-related memory impairment: Neuropsychological predictors of dementia
23. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII
24. Alzheimer's disease, depression and normal aging: Merit of simple psychomotor and visuospatial tasks
25. Predictors of institutionalization for people with dementia living at home with a carer
26. Screening for organic mental syndromes in the medically ill
27. Overlap between pathology of Alzheimer disease and vascular dementia
28. A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia
29. Detection of cognitive deficits by a brief mental state examination: The cognitive capacity screening examination, a reappraisal and a review
30. Poststroke depression and emotional incontinence: Correlation with lesion location
31. Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: A preliminary positron emission tomography study
32. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization
33. Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease
34. The 'preclinical phase' of probable Alzheimer's disease
35. A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia
36. Improved cognition after control of risk factors for multi-infarct dementia
37. Problems encountered with longitudinal neurological, psychometric and cerebral CT imaging among stroke data bank patients with dementia
38. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia
39. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease
40. The effects of additional pathology on the cognitive deficit in Alzheimer disease
41. Bedside cognitive screening instruments
42. Vascular dementia: A contemporary review of epidemiology, diagnosis, prevention, and treatment
43. White matter changes in depression and Alzheimer's disease: A review of magnetic resonance imaging studies
44. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease
45. Functional and cognitive impairment in Alzheimer's patients with and without depression
46. Mild cognitive impairment: Clinical characterization and outcome
47. A case of mistaken identity: Pseudodementia is really predementia
48. Two-year follow-up of elderly patients with mixed depression and dementia. Clinical and electroencephalographic sleep findings
49. Progressive disability in senile dementia is accelerated in the presence of depression
50. The influence of major depression on clinical and psychometric assessment of senile dementia of Alzheimer type
51. Is subcortical disease associated with a poor response to antidepressant? Neurological, neuropsychological and neuroradiological findings in late-life depression
52. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study
53. Psychiatric problems and nursing home placement of patients with Alzheimer's disease
54. Distinction between preclinical Alzheimer's disease and depression
55. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia
56. What depressive symptoms are reported in Alzheimer's patients?